- Aptar Pharma's Consumer Healthcare division in Europe received P&G's 2025 External Business Partner Excellence Award.
- The award recognizes top-performing suppliers from P&G's network of over 50,000 partners.
- Only 40 suppliers worldwide were selected for their performance and contributions over the past 12–24 months.
- P&G emphasizes strong partnerships for innovation and shared success.
Recognition by P&G
Aptar Pharma's Consumer Healthcare division in Europe has been honored with the 2025 External Business Partner Excellence Award by P&G. This accolade places Aptar Pharma among the top-performing suppliers in P&G's extensive global network.
Selection Criteria
The award acknowledges suppliers who have demonstrated exceptional performance, partnership, and excellence. Out of more than 50,000 external partners, only 40 suppliers worldwide were selected for their outstanding contributions over the past 12–24 months.
Importance of Partnerships
Ana Elena Marziano, P&G's Chief Purchasing Officer, highlighted the significance of strong partnerships in fostering innovation and shared success. The Excellence Awards reflect P&G's commitment to collaboration, execution, and breakthrough thinking that benefits the entire supply network.
